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PURPOSE: To evaluate the clinical and laboratory characteristics of pleural effusions secondary to tuberculosis (TB) or cancer
(CA).
METHODS: A total of 326 patients with pleural effusion due to TB (n=182) or CA (n=144) were studied. The following parameters
were analyzed: patient gender, age and pleural effusion characteristics (size, location, macroscopic fluid aspect, protein concentration,
lactate dehydrogenase (DHL) and adenosine deaminase activity (ADA) and nucleated cell counts).
RESULTS: Young male patients predominated in the tuberculosis group. The effusions were generally moderate in size and
unilateral in both groups. Yellow-citrine fluid with higher protein (p < 0.001) levels predominated in effusions from the tuberculosis
group (5.3 + 0.8 g/dL) when compared to the CA group (4.2 ± 1.0 g/dL), whereas DHL levels were more elevated in CA (1,177 ±
675 x 1,030 ± 788 IU; p = 0.003) than in TB. As expected, ADA activity was higher in the TB group (107.6 ± 44.2 x 30.6 ± 57.5
U/L; p < 0.001). Both types of effusions presented with high nucleated cell counts, which were more pronounced in the malignant
group (p < 0.001). TB effusion was characterized by a larger percentage of leukocytes and lymphocytes (p < 0.001) and a smaller
number of mesothelial cells (p = 0.005). Lymphocytes and macrophages were the predominant nucleated cell in neoplastic effusions.
CONCLUSION: Our results demonstrate that in lymphocytic pleural exudate obtained from patients with clinical and radiological
evidence of tuberculosis, protein and ADA were the parameters that better characterize these effusions. In the same way, when the
clinical suspicion is malignancy, serous-hemorrhagic lymphocytic fluid should be submitted to oncotic cytology once this easy
and inexpensive exam reaches a high diagnostic performance (≅ 80%). In this context, we suggest thoracocentesis with fluid
biochemical and cytological examination as the first diagnostic approach for these patients.
KEY-WORDS: Pleural effusion. Neoplasm. Tuberculosis. Adenosine deaminase. Exudates.
INTRODUCTION
The first step in the etiological investigation of a pleu-
ral effusion is to determine whether the effusion is a tran-
sudate or an exudate. Transudates reflect the presence of
systemic disease with repercussions on the mechanisms of
pleural fluid production and resorption1. In contrast, exu-
dates reflect the presence of primary pleural disease and
require etiological investigation1. However, considering
worldwide epidemiological aspects, most cases of pleural
effusion in Brazil result as a consequence of tuberculosis
or cancer2,3. In this respect, although differential diagnosis
must be a priority, it is often difficult due to the similar
biochemical profiles and the predominance of lymphocytes
in both conditions.
The gold standard for diagnosis of pleural tuberculosis
is the identification of Mycobacterium tuberculosis in pleu-
ral fluid or tissue4. However, in clinical practice this iden-
tification is problematic because of the low identification
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rate of the bacillus (less than 30% in pleural fluid and ap-
proximately 50% in the pleura) and the slow growth of
mycobacterium in culture (about 60 days)4. Therefore, in
regions with a high prevalence of tuberculosis, pleural bi-
opsy demonstrating a granulomatous inflammatory proc-
ess is used for diagnosis since other granulomatous diseases
such as sarcoidosis, mycosis and rheumatoid arthritis ac-
count for less than 10% of granulomatous findings in the
pleura5.
On the other hand, the diagnosis of neoplastic pleural
effusion is made based on the presence of malignant cells
in the pleural fluid or tissue. The positivity rate of the cy-
tological exam ranges from 40 to 87%, higher than that
obtained with a needle biopsy which ranges from 35 to
65%1,6.
In this context, the objective of the present study was
to describe the characteristics and laboratory performance
of pleural fluid biochemical and cytological parameters
from patients with tuberculosis or cancer.
METHODS
A total of 326 consecutive patients from the Pleural
Outpatient Clinic with a diagnosis of pleural effusion due
to tuberculosis (n=182) or cancer (n=144) were included.
The criteria for establishment of the diagnosis of tubercu-
losis were: a) pleural biopsy demonstrating a granuloma-
tous process, b) detection of M. tuberculosis in pleural fluid
or tissue, and c) a compatible clinical history and radio-
logic exams, in patients with a lymphocytic exudate and
adenosine deaminase (ADA) levels higher than 40 U/L as
well as favorable clinical evolution after specific treatment.
The diagnosis of cancer was based on the finding of
neoplastic cells in pleural fluid or tissue obtained by nee-
dle biopsy. In inconclusive cases, diagnosis was established
by thoracoscopy-guided biopsy, transbronchial biopsy or
surgery.
The following variables were analyzed: gender, age and
characteristics of the pleural effusion including size (evalu-
ated by chest X-ray - postero-anterior and lateral views)
which was classified according to involvement of hemitho-
rax as: discrete (<25%); moderate (25 to 75%) or intense
(>75%). Location (uni- or bilateral) and macroscopic as-
pects of the pleural fluid (yellow-citrine, serohemorrhagic
or chylous) were also evaluated. Total protein concentra-
tion (colorimetric biuret reaction, Cobas Integra 700) and
lactate dehydrogenase (LDH) levels (kinetic ultraviolet
method, Cobas Integra 700) were assayed in pleural fluid
samples collected without the addition of anticoagulant.
Samples collected with EDTA were used for oncotic cy-
tology and cell count and for the quantification of ADA
(colorimetric method of Giusti et al.7).
The study was approved by the local Ethics Commit-
tee and all patients signed a free informed consent form.
Statistical Analysis. The Mann-Whitney test and Z test
were used for comparison between groups, with differences
being considered significant when p < 0.05. Statistical
analysis was performed using the SigmaStat program
(V2.03; Jandel Scientific, San Rafael, CA).
RESULTS
The demographic data of the patients and the charac-
teristics of the pleural effusions are shown in table 1. Pa-
tients with tuberculosis were significantly (p < 0.001)
younger (36.7 ± 13.6 years) than those with cancer (58.5
± 14.5 years). Among patients with tuberculosis, there was
a predominance (p < 0.001) of males (132/182; 72.5%) over
females (50/182; 27.5%), while the opposite was observed
in the cancer group (females: 95/144, 66% versus males:
49/144, 34%; p < 0.001). This finding reflects the charac-
teristics of our outpatient clinic, where mainly breast can-
cer patients are seen.
With respect to fluid volume, we observed a predomi-
nance of moderate effusion in both groups (tuberculosis:
142/182; 78%, and cancer: 103/144; 71.5%), with no sig-
nificant difference between them (p = 0.187). Although
most effusions were moderate, the lowest volumes (<25%)
were observed in the tuberculosis group (32/182; 17.6%),
whereas more voluminous effusions (>75%) were most fre-
quent in the cancer group (40/144; 27.8%). Unilateral ef-
Table 1 - Demographic data and characteristics of the pleural
effusions.
Tuberculosis Cancer p
N 182 144  NS
Age (years) 36.7 ± 13.6 58.5 ± 14.5 < 0.001
Gender (M/F) 132/50 49/95 < 0.001
(72.5/27.5%) (34/66%)
Size (% of the hemithorax)
< 25 32 (17.6%) 1 (0.7%) < 0.001
25 – 75 142 (78.0%) 103 (71.5%)  0.187
> 75 8 (4.4%) 40 (27.8%) < 0.001
Location
Unilateral 174 (95.6%) 133 (92.4%)  0.381
Bilateral 8 (4.4%) 11 (7.6%)  0.342
Aspect
Yellow-citrine 161 (88.5%) 69 (47.9%) < 0.001
Serohemorrhagic 21 (11.5%) 73 (50.7%) < 0.001
Chylous 0 (0%) 2 (1.4%)
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fusions predominated in both tuberculosis (174/182; 95.6%)
and cancer (133/144; 92.4%) groups.
Macroscopically, most pleural effusions presented a yel-
low-citrine aspect (230/326; 70.5%), demonstrating a sig-
nificant difference (p < 0.001) between the tuberculosis
(161/182; 88.5%) and cancer (69/144; 47.9%) groups. Al-
though half of these effusions were yellow-citrine,
serohemorrhagic effusions predominated (p< 0.001) in the
cancer group (73/144; 50.7%) when compared to the tu-
berculosis group (21/182; 11.5%).
Table 2 shows the biochemical and cytological charac-
teristics of the pleural fluids. Protein concentrations were
significantly higher (p < 0.001) in the tuberculosis group
(5.3 ± 0.8 g/dL) compared to the cancer group (4.2 ± 1.0
g/dL). In contrast, LDH levels were higher (p = 0.003) in
the cancer group (1,177 ± 675 IU) than in the tuberculosis
(1,030 ± 788 IU) group. Finally, as expected, ADA levels
were significantly higher in the tuberculosis group (107.6
± 44.2 U/L versus 30.6 ± 57.5 U/L; p < 0.001).
Although the pleural effusions were characterized by
high cellularity, neoplastic effusions were more richly cel-
lular than tuberculous effusions (3,058 ± 1,807 versus 2,860
± 2,194 cells/mm3; p < 0.001). Analysis of the proportion
of nucleated cells revealed a significantly lower percent-
age of mesothelial cells in the tuberculosis group (1.3 ±
2.2% versus 6.1 ± 1.6%; p = 0.005), whereas the percent-
age of macrophages was significantly higher (p < 0.001)
in the cancer group (33.2 ± 23.4% versus10.5 ± 10.2%).
A higher proportion of leukocytes (p < 0.001) was observed
in the tuberculosis group (87.8 ± 11.7%) when compared
to the cancer group (57.5 ± 26.8%). Although both effu-
sions were lymphocytic, the number of lymphocytes was
significantly higher (p < 0.001) in the tuberculosis (88.9 ±
19.7%) compared to the cancer group (81.7 ± 22.4%).
In cancer effusions, oncotic cytology was positive in
70% (101/144) of cases and highly suggestive in 19.2% (28/
144), permitting suspicion or confirmation of diagnosis in
approximately 90% of the patients. A second pleural ap-
proach (thoracocentesis) confirmed the diagnosis of can-
cer in four suspected cases and in additional two whose
cytology was negative. In the remaining 24 patients, cy-
tology was inconclusive. The diagnosis of cancer was con-
firmed by immunophenotyping of pleural fluid in four cases
(lymphoma), by closed pleural biopsy in 13 (carcinoma),
and by thoracoscopy-guided pleural biopsy in seven (car-
cinoma).
Closed pleural biopsy was conclusive in 68/78 (87.1%)
and 21/37 (56%) of tuberculosis and cancer patients, re-
spectively. A second pleural biopsy increased the cancer
rate to 23/37 (62.1%).
DISCUSSION
A systematic approach to the classification of pleural
effusion permits the diagnosis of a large number of pleu-
ral diseases, especially when considering the high incidence
of tuberculosis and cancer in Brazil. Diagnostic explora-
tion is based on the analysis of clinical variables (gender,
age and symptoms), imaging characteristics (volume and
location of fluid), and laboratory (biochemical and cyto-
logical) data.
A detailed clinical history of previous neoplasms or
complaints related to consumptive states, as well as the
presence of fever, night sweats, cough and contact with tu-
berculous patients are fundamental. Since thoracocentesis
is the first approach proposed in cases of pleural effusion,
analysis of the removed fluid is the easiest and fastest way
of assessment8. Although the cause of pleural effusion re-
mains indeterminate in about 20% of cases, cytological,
biochemical and microbiological analysis of pleural fluid
is fundamental for adequate screening, avoiding more ex-
pensive exams that would increase the morbidity and/or
mortality of the patient9.
Tuberculosis is a ubiquitous disease with a high preva-
lence in Brazil3. This disease usually predominates among
individuals younger than those affected by cancer, a fact
confirmed in the present study in which only 4.2% of the
cases of tuberculosis occurred in patients older than 35
Table 2 - Biochemical and cytological characteristics of the pleural fluids.
Tuberculosis Cancer p
Protein (g/dl) 5.3 ± 0.8 4.2 ± 1.0 < 0.001
DHL UI 1,030 ± 788 1,177 ± 675 0.003
ADA (U/L) 107.6 ± 44.2 30.6 ± 57.5 < 0.001
Nucleated cell count (mm3) 2,860 ± 2,194 3,058 ± 1,807 < 0.001
Mesothelial cells (%) 1.3 ± 2.2 6.1 ± 1.6 0.005
Macrophages (%) 10.5 ± 10.2 33.2 ± 23.4 < 0.001
Leukocytes (%) 87.8 ± 11.7 57.5 ± 26.8 < 0.001
Granulocytes (%) 7.6 ± 16.6 13.3 ± 19.2 < 0.001
Lymphocytes (%) 88.9 ± 19.7 81.7 ± 22.4 < 0.001
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(only one patient older than 60) years. However, in the state
of São Paulo (1998 to 2000), notifications of pleural effu-
sion due to tuberculosis indicate that 40% of cases occurred
in male individuals older than 40 years.2 Thus, although
important, age should only be considered as a complemen-
tary variable in the diagnosis of tuberculosis.
With respect to gender, it is known that men are more
predisposed to both tuberculosis10 and lung cancer,11,12 al-
though the incidence of cancer has been increasing among
women over the last few decades. The predominance of fe-
males among patients with cancer observed in the present
study is in contrast to international epidemiological data.
This bias is easily explained by the tertiary character of
our hospital, which is a referral center for cancer with pleu-
ral involvement, particularly that secondary to breast can-
cer.
The pleural effusions were moderate in most patients
with tuberculosis or cancer, with unilateral effusions pre-
dominating in more than 90% of cases. This finding agrees
with literature showing that pleural effusions are preferen-
tially unilateral and moderate.1,12 Despite this similarity, a
higher incidence of voluminous collections is found in ma-
lignant pleural effusions, a fact also observed in the present
study1.
After evaluation of demographic variables and chest
images, the pleural space should be submitted to invasive
investigation. The first step is thoracocentesis, i.e., thoracic
puncture for pleural fluid collection, with the objective, in
addition to the determination of macroscopic aspects, of
material collection for adequate laboratory examination.
Yellow-citrine fluid (sometimes slightly turbid) pre-
dominates in tuberculosis while serohemorrhagic fluid pre-
dominates in cancer. Our results confirmed this observa-
tion8,13 but also showed overlaps between the groups con-
cerning the classification of pleural effusion based only on
this variable.
As a rule, thoracocentesis should always be considered
for collection of pleural fluid for diagnosis. Only in excep-
tional cases, when diagnosis has already been established
or during an emergency (respiratory insufficiency), will it
be performed when no laboratory infrastructure is available.
Otherwise, thoracocentesis should include fluid collection
and subsequent biochemical and cytological exams.
The first parameters analyzed (LDH and protein) should
permit the differentiation between a transudate and an exu-
date (Light’s criteria).14 Clinically, this discrimination is
extremely valuable, since transudative effusions generally
reflect systemic diseases and therefore do not require a
complementary diagnostic approach. On the other hand,
exudates indicate pleural involvement resulting from sys-
temic disorders or primary pleural diseases. In these cases,
diagnostic exploration should be complemented by other
pleural fluid exams or histological evaluation of the
pleura.1,8
Since our objective was to differentiate between tuber-
culosis and cancer, the first step was to recognize the pres-
ence of an exudate. All pleural effusions included in the
study were exudates and, although not specific, protein lev-
els were significantly higher in the tuberculosis group, in
agreement with the findings of Liam et al.15 Since the pro-
tein concentration in pleural tuberculosis is frequently
higher than 4.5 g/dL, Melo et al.16 proposed this value as
a cutoff for diagnostic presumption. As confirmation of this
proposal, this was the minimum protein level detected in
the present study.
Lactic dehydrogenase, a nonspecific inflammatory
marker,8 is in general discretely elevated in pleural tuber-
culosis. Neoplasms present higher levels, suggesting a
greater extent of pleural disease or the presence of blood
in the pleural cavity.17 Despite this difference and, as is the
case for the macroscopic evaluation of effusion, these bio-
chemical parameters do not permit differentiation between
the two diseases because of overlapping values.
The next step is the quantification of ADA, an enzyme
produced by macrophages and activated T lymphocytes,18
which is usually elevated in tuberculosis. In this situation,
the activity of the enzyme is generally higher than 40 U/
L, although similar levels are observed in lymphocytic pleu-
ral effusions secondary to rheumatoid arthritis and certain
lymphoproliferative diseases. Other lymphocytic exudates,
such as those secondary to pulmonary edema or metastatic
tumors, generally show levels below 40 U/L.19-22 In the
present study, using a cutoff value of 40 U/L as a presump-
tive diagnosis, all cases of tuberculosis were correctly clas-
sified. This cutoff value shows high efficiency in the clas-
sification of lymphocytic effusions (sensitivity: 87 to 100%
and specificity: 81 to 97%).19-25 Despite the high diagnos-
tic sensitivity of ADA, its specificity is influenced by other
clinical conditions and by the regional prevalence of tu-
berculosis.26,27
In the present study, 13 (9%) patients with cancer pre-
sented an ADA activity higher than 40 U/L. Five of these
patients had lymphomas (diagnosed by immunopheno-
typying) and eight had solid tumors. Despite increased
ADA levels, etiological diagnosis was established in seven
of these cases by pleural fluid cytology. In one case, both
cytology and pleural biopsy were negative. However, chest
X-ray demonstrated a pulmonary mass and the diagnosis
of undifferentiated lung carcinoma was established by
transbronchial biopsy. In the remaining five cases, a closed
pleural biopsy (n=3) or thoracoscopy-guided biopsy (n=2)
led to a definitive diagnosis.
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Considering the cytological profile of the pleural flu-
ids in these two diseases, no cellular finding is character-
istic, with exception to the presence of neoplastic cells in
cancer effusions.
Oncotic cytology of the pleural fluid is considered to
be the most sensitive method for the diagnosis of malig-
nant pleural effusion.1,8 However, its performance varies
according to the histological type and exfoliative capacity
of the tumor, the techniques used to process the pleural
samples, the number of slides analyzed per case and, fi-
nally, the cytologist expertise. These factors explain the
variation in the efficacy of the exam (40 to 87%) reported
in the literature.28 In this study, the first fluid examination
led to the diagnosis of cancer in 70.1% (101) of cases. In
19.4% (28), oncotic cytology was highly suspicious of ma-
lignancy and in 10.5% (15) it was negative. A second
method performed in the 28 suspicious patients (thoraco-
centesis: 4; immunophenotyping: 4; closed pleural biopsy:
13 and VATS: 7) defined the diagnosis of neoplasia. In all
patients (15) with negative cytology, the diagnosis of can-
cer was confirmed.
This study demonstrates that although the pleural effu-
sion exudates secondary to tuberculosis or cancer were pre-
dominantly lymphocitic, some clinical and laboratory as-
pects could aid in their differentiation. In general, tuber-
culosis occurred in younger persons, and effusions were
unilateral and of a median size. The pleural fluid was fre-
quently yellow (citrine or turbid) with high protein and
ADA levels and with a low number of mesothelial cells.
In contrast, patients with malignant effusions were gener-
ally older and, although the effusions were predominantly
unilateral, the presence of a bilateral effusion was more as-
sociated with malignancy. In addition, the fluid was pre-
dominantly turbid or serohemorrhagic. The level of pro-
tein was lower than in tuberculosis, while ADA was nor-
mal and LDH was frequently higher. Cytological exami-
nation revealed a predominance of lymphocytes and
macrophages. In patients with clinical and radiological evi-
dence of tuberculosis presenting an exudative effusion rich
in lymphocytes, protein and ADA levels are important to
the etiological diagnosis. Similarly, when the clinical sus-
picion is malignancy, serous hemorrhagic limphocytic fluid
should be submitted to oncotic cytology, once this easy and
inexpensive exam is an efficient diagnostic tool (≅ 80%).
As a result, we suggest thoracocentesis with pleural fluid
examination as the first diagnostic approach.
RESUMO
Antonangelo L, Vargas FS, Seiscento M, Bombarda S,
Teixeira L, Sales RKB. Parâmetros clínicos e laboratoriais
no diagnóstico diferencial de efusões pleurais secundárias
à tuberculose ou ao cancer. Clinics.2007;62(5):585-90.
OBJETIVO: Avaliar as características clínicas e labora-
toriais de derrames pleurais secundários à tuberculose ou
câncer.
MÉTODOS: Um total de 326 pacientes com derrame pleural
por tuberculose (n=182) ou câncer (n=144) foi avaliado. Os
seguintes parâmetros foram analisados: sexo e idade dos pa-
cientes e características do líquido pleural (tamanho, locali-
zação, aspecto macroscópico, concentração de proteínas, ati-
vidade da desidrogenase lática (DHL) e da adenosina
deaminase (ADA) e contagem de células nucleadas).
RESULTADOS: A tuberculose pleural predominou nos pa-
cientes mais jovens e do sexo masculino. Em ambos os gru-
pos, os derrames pleurais foram de tamanho moderado e uni-
laterais. Derrames com aspecto amarelo-citrino com níveis
mais elevados de proteínas predominaram na tuberculose (5,3
± 0,8 g/dL), quando comparados aos neoplásicos (4,2 ± 1,0
g/dL), enquanto que níveis mais elevados de DHL foram
observados nos derrames neoplásicos (1.177 ± 675 x 1.030
± 788 UI; p = 0,003). Conforme esperado, a atividade da
ADA foi maior na tuberculose que no câncer (107,6 ± 44,2
x 30,6 ± 57,5 U/L; p < 0,001). Ambos os derrames apresen-
taram alta celularidade, embora mais pronunciada no grupo
neoplásico (p < 0,001). Os derrames de etiologia tuberculosa
se caracterizaram por apresentar uma maior percentagem de
leucócitos e de linfócitos (p < 0,001) e um pequeno número
de células mesoteliais (p = 0,005). Linfócitos e macrófagos
foram as células nucleadas que predominaram nos derrames
pleurais malignos.
CONCLUSÃO: Nossos resultados demonstram que em
exsudatos pleurais linfocíticos de pacientes com evidênci-
as clínicas e radiológicas de tuberculose, os níveis de pro-
teína e de ADA foram os parâmetros que melhor caracte-
rizaram esses derrames. Da mesma maneira, quando a sus-
peita clínica é câncer, um líquido serohemorrágico e
linfocítico deve ser submetido à citologia oncótica, uma
vez que este exame laboratorial de fácil realização e bai-
xo custo apresenta alto desempenho diagnóstico (≅ 80%).
Neste contexto, sugerimos que a toracocentese, com exa-
mes bioquímicos e citológicos do líquido pleural, seja a
primeira abordagem diagnóstica do paciente.
UNITERMOS: Derrame pleural. Neoplasia. Tuberculose
pleural. Adenosina deaminase. Exsudatos.
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